• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性硬化症2型/多囊肾病1型连续基因缺失综合征的分子分析

Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome.

作者信息

Oyazato Yoshinobu, Iijima Kazumoto, Emi Mitsuru, Sekine Takashi, Kamei Koichi, Takanashi Junichi, Nakao Hideto, Namai Yoshiyuki, Nozu Kandai, Matsuo Masafumi

机构信息

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.

出版信息

Kobe J Med Sci. 2011 Jun 9;57(1):E1-10.

PMID:22169896
Abstract

BACKGROUND

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in either of two genes, TSC1 and TSC2. Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in either PKD1 or PKD2. TSC2 lies immediately adjacent to PKD1 and large heterozygous deletions can result in the TSC2/PKD1 contiguous gene syndrome (PKDTS). PKDTS has been identified in patients with TSC and early-onset severe ADPKD. However, genetic diagnosis with conventional methods proved to be difficult because its genetic aberrations are large monoallelic mutations.

METHODS

In the study presented here, we used both multiplex ligation-dependent probe amplification (MLPA) and array comparative genomic hybridization (array-CGH) for four PKDTS patients.

RESULTS

We were able to detect large heterozygous deletions including TSC2 and PKD1 by both of MLPA and array-CGH in all four patients. And in two patients, array-CGH identified relatively large genomic aberrations (RAB26, NTHL1, etc.), that extended outside of TSC2 or PKD1.

CONCLUSION

The identical results obtained with these two completely different methods show that both constitute highly reliable strategies. Only a few studies have determined the breakpoints of large deletions in this disease and ours is the first to have identified the breakpoints by using array-CGH. We suggest that these methods are not only useful for the diagnosis of PKDTS but also for elucidation of its molecular mechanism.

摘要

背景

结节性硬化症(TSC)是一种常染色体显性疾病,由TSC1和TSC2这两个基因中的任意一个发生突变引起。常染色体显性多囊肾病(ADPKD)由PKD1或PKD2发生突变引起。TSC2紧邻PKD1,大的杂合性缺失可导致TSC2/PKD1相邻基因综合征(PKDTS)。PKDTS已在患有TSC和早发性严重ADPKD的患者中得到确认。然而,由于其基因畸变是大的单等位基因突变,用传统方法进行基因诊断很困难。

方法

在本文介绍的研究中,我们对4例PKDTS患者同时使用了多重连接依赖探针扩增技术(MLPA)和阵列比较基因组杂交技术(array-CGH)。

结果

我们通过MLPA和array-CGH在所有4例患者中均检测到包括TSC2和PKD1的大的杂合性缺失。在2例患者中,array-CGH识别出相对较大的基因组畸变(RAB26、NTHL1等),这些畸变延伸至TSC2或PKD1之外。

结论

这两种完全不同的方法得到相同结果,表明二者均是高度可靠的策略。仅有少数研究确定了该疾病中大缺失的断点,而我们的研究是首次通过使用array-CGH确定断点。我们认为这些方法不仅对PKDTS的诊断有用,而且对阐明其分子机制也有用。

相似文献

1
Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome.结节性硬化症2型/多囊肾病1型连续基因缺失综合征的分子分析
Kobe J Med Sci. 2011 Jun 9;57(1):E1-10.
2
TSC2/PKD1 contiguous gene syndrome: a report of 2 cases with emphasis on dermatopathologic findings.结节性硬化症2型/多囊肾病1型相邻基因综合征:2例报告并着重阐述皮肤病理学发现
Am J Dermatopathol. 2009 Aug;31(6):532-41. doi: 10.1097/DAD.0b013e3181970e44.
3
Diagnosis and genotype-phenotype correlation in patients with PKD1/TSC2 contiguous gene deletion syndrome.PKD1/TSC2 连续基因缺失综合征患者的诊断和基因型-表型相关性。
Clin Nephrol. 2022 Jun;97(6):328-338. doi: 10.5414/CN110476.
4
[TSC2/PKD1 contiguous gene deletion syndrome].[结节性硬化症2型/多囊肾病1型连续基因缺失综合征]
An Pediatr (Barc). 2013 Jul;79(1):42-5. doi: 10.1016/j.anpedi.2012.12.004. Epub 2013 Feb 9.
5
Gross genomic rearrangement involving the TSC2-PKD1 contiguous deletion syndrome: characterization of the deletion event by quantitative polymerase chain reaction deletion assay.涉及结节性硬化症2型-多囊肾病1型连续缺失综合征的基因组重排:通过定量聚合酶链反应缺失分析对缺失事件进行特征分析
Am J Kidney Dis. 2007 Jan;49(1):e11-21. doi: 10.1053/j.ajkd.2006.10.024.
6
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.常染色体显性多囊肾病及PKD1/TSC2相邻基因综合征中大重排的特征分析。
Kidney Int. 2008 Dec;74(11):1468-79. doi: 10.1038/ki.2008.485. Epub 2008 Sep 24.
7
Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.通过TSC2变性梯度凝胶电泳(DGGE)、TSC1/TSC2多重连接探针扩增(MLPA)以及TSC1长片段PCR测序对65例结节性硬化症(TSC)患者进行分析,并报告28个新突变。
Hum Mutat. 2005 Oct;26(4):374-83. doi: 10.1002/humu.20227.
8
Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome.与严重婴儿型多囊肾病相关的TSC2和PKD1基因缺失——一种相邻基因综合征。
Nat Genet. 1994 Dec;8(4):328-32. doi: 10.1038/ng1294-328.
9
Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.结节性硬化症合并常染色体显性多囊肾病的影像学特征:一种相邻基因综合征
Pediatr Radiol. 2015 Mar;45(3):386-95. doi: 10.1007/s00247-014-3147-1. Epub 2014 Oct 30.
10
Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated.当多囊肾病1(PKD1)和结节性硬化症2(TSC2)发生突变时对雷帕霉素靶蛋白(mTOR)抑制反应的深入了解。
BMC Med Genet. 2015 Jun 17;16:39. doi: 10.1186/s12881-015-0185-y.

引用本文的文献

1
Tuberous sclerosis presenting along with autosomal dominant polycystic kidney disease (ADPKD): A rare presentation.结节性硬化症合并常染色体显性多囊肾病(ADPKD):一种罕见的表现。
Bioinformation. 2025 May 31;21(5):1705-1708. doi: 10.6026/973206300211705. eCollection 2025.
2
Tuberous Sclerosis Complex: A Case Series from a Romanian Genetics Center and a Review of the Literature.结节性硬化症:来自罗马尼亚遗传学中心的病例系列及文献综述
J Clin Med. 2025 Apr 25;14(9):2974. doi: 10.3390/jcm14092974.
3
An overview of actionable and potentially actionable TSC1 and TSC2 germline variants in an online Database.
在线数据库中可操作和潜在可操作的TSC1和TSC2种系变体概述。
Genet Mol Biol. 2024 Feb 19;46(3 Suppl 1):e20230132. doi: 10.1590/1678-4685-GMB-2023-0132. eCollection 2024.
4
Comprehensive Genetic Analysis Results of TSC1/TSC2 Genes in Patients with Clinical Suspicion of Tuberous Sclerosis Complex and Definition of 3 Novel Variants.全面的 TSC1/TSC2 基因遗传分析结果在有结节性硬化症临床可疑表现的患者中,并定义了 3 种新的变异。
Balkan Med J. 2021 Nov;38(6):341-347. doi: 10.5152/balkanmedj.2021.21092.
5
Novel Roles of SH2 and SH3 Domains in Lipid Binding.SH2 和 SH3 结构域在脂质结合中的新作用
Cells. 2021 May 13;10(5):1191. doi: 10.3390/cells10051191.
6
Solution NMR Structure of the SH3 Domain of Human Caskin1 Validates the Lack of a Typical Peptide Binding Groove and Supports a Role in Lipid Mediator Binding.人源 Caskin1 的 SH3 结构域的溶液 NMR 结构证实其缺乏典型的肽结合凹槽,并支持其在脂质介质结合中的作用。
Cells. 2021 Jan 16;10(1):173. doi: 10.3390/cells10010173.
7
Molecular diagnosis of an infant with / contiguous gene syndrome.一名患有/相邻基因综合征婴儿的分子诊断。
Hum Genome Var. 2020 Jul 16;7:21. doi: 10.1038/s41439-020-0108-0. eCollection 2020.
8
Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.严重多囊肝病并非由PRKCSH基因的大片段缺失所致。
J Clin Lab Anal. 2016 Sep;30(5):431-6. doi: 10.1002/jcla.21875. Epub 2015 Sep 13.
9
Renal involvement in tuberous sclerosis complex with emphasis on cystic lesions.结节性硬化症的肾脏受累,重点在于囊性病变。
Radiol Med. 2016 May;121(5):402-8. doi: 10.1007/s11547-015-0572-7. Epub 2015 Jul 29.
10
Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated.当多囊肾病1(PKD1)和结节性硬化症2(TSC2)发生突变时对雷帕霉素靶蛋白(mTOR)抑制反应的深入了解。
BMC Med Genet. 2015 Jun 17;16:39. doi: 10.1186/s12881-015-0185-y.